VA-REGULA
3.7.2024 08:01:34 CEST | Business Wire | Press release
Regula, a global developer of forensic devices and identity verification solutions, has released a significant update to its operating software, Regula Forensic Studio. This major revamp enhances the functionality of forensic devices, improves usability, streamlines operations, and allows for more precise document examination.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240702630951/en/
A forensic expert examines a banknote with the help of a Regula device and Regula Forensic Studio software (Photo: Regula)
Compatible with Regula’s most recent advanced forensic devices, including the company’s flagship dual-video spectral comparator, Regula 4308, Regula Forensic Studio software facilitates manual examination of handwritten texts, banknotes, travel and identity documents, collectibles, and more. Supplied in a bundle with forensic devices and available out-of-the-box, Regula Forensic Studio can operate all Regula devices in a forensic laboratory, creating a smooth user experience and allowing for a wide range of examinations.
The new features and improvements in Regula Forensic Studio significantly elevate the user experience, as well as the convenience, speed, and accuracy of forensic examination.
Crucial examination speed and precision enhancements include:
- A new cross-platform architecture that significantly streamlines document processing and reporting, and ensures full compatibility with all popular operating systems, such as Windows, Linux, and macOS.
- The possibility of creating predefined scenarios (macros) for repetitive tasks, which makes it possible to automate the verification process for certain types of documents. For example, if an expert needs to verify a wad of banknotes, they can automatically record the sequence of checks (including all the lighting and filtering techniques) for one banknote, and auto-repeat it for the rest of the wad. Not only does this feature streamline the whole process, but also eliminates human-related errors.
- Fully automated ID verification in mere seconds through seamless integration with Regula Document Reader SDK, which instantly recognizes the document type and validates all its data from MRZs, RFID chips, barcodes, and performs available security checks.
- Enhanced integration with the Information Reference System (IRS), which makes it simple to compare an examined document to its reference image from the database. Thanks to real-time sync between RFS and the Information Reference System, the device's active light source is switched to the one used in the reference sample, and vice versa. This leads to more quick and efficient examinations.
- Automated banknote residual area measurement, a new feature that was added as a response to customers’ needs. It uses banknote references from the Regula IRS to automatically measure the undamaged area of a banknote and determine if it can be accepted by the bank.
Key usability enhancements include:
- A new intuitive user-friendly interface.
- Multi-screen support to allow users to drag and drop application tabs between monitors, which is especially convenient when working with several images.
- Colored image superimposition, a new feature that highlights different elements of two images for easier comparison.
- Pseudocolor visualization, a feature that uses substitute bright colors to highlight areas within the same color (like some indistinguishable shades of gray) for better visualization.
- Automatic detection of Machine Identification Code (MIC), a new feature that detects a unique yellow-dot pattern color laser printers and copiers leave on paper sheets. This helps identify the source of printed documents.
“In the crowded field of ID verification, Regula has distinguished itself by constantly improving, as well as adopting a customer-centric approach at the core of our research and development. The updated Regula Forensic Studio software has become notably faster and more efficient. It reflects feedback from external forensic experts and our customers, and incorporates features designed to address specific use cases and improve operations. This user-centric approach helps us boost the functionality of our solutions and meet the evolving needs of our customers in the most efficient way,” says Ihar Kliashchou, Chief Technology Officer at Regula.
To see the full list of new features and capabilities and learn more about the recent update of Regula Forensic Studio, please visit Regula’s website.
About Regula
Regula is a global developer of forensic devices and identity verification solutions. With our 30+ years of experience in forensic research and the largest library of document templates in the world, we create breakthrough technologies in document and biometric verification. Our hardware and software solutions allow over 1,000 organizations and 80 border control authorities globally to provide top-notch client service without compromising safety, security, or speed. Regula has been repeatedly named a Representative Vendor in the Gartner® Market Guide for Identity Verification.
Learn more at www.regulaforensics.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240702630951/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma’s Nemluvio® (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years27.2.2026 07:00:00 CET | Press release
Results from an interim analysis of the OLYMPIA long-term extension (LTE) study show that Nemluvio maintained long-term disease control up to three years, with clinically meaningful improvements in itch intensity, skin lesions and quality of life1 These results, to be presented at 2026 Winter Clinical™ Miami, mark the longest LTE study in prurigo nodularis reported to date1 Nemluvio is the first approved monoclonal antibody that specifically targets and inhibits the signaling of IL-31 – a neuroimmune cytokine that drives itch and other symptoms in prurigo nodularis2-5 Nemluvio is approved by multiple regulatory authorities around the world for the treatment of prurigo nodularis and moderate-to-severe atopic dermatitis, including in the United States (U.S.) and European Union (EU)4,5 Galderma (SIX: GALD) today announced new data from the OLYMPIA open-label extension study investigating the long-term safety and efficacy of Nemluvio in moderate-to-severe prurigo nodularis.1 Results showed
Venture Global Announces New Long-Term LNG Partnership with Hanwha of Korea27.2.2026 01:00:00 CET | Press release
20-year sales and purchase agreement marks Venture Global’s first SPA with a Korean entity Today, Venture Global, Inc. (NYSE: VG) and Hanwha Aerospace Co., Ltd. announced the execution of a new Sales and Purchase Agreement (SPA) for the purchase of 1.5 million tonnes per annum (MTPA) of U.S. liquefied natural gas (LNG) from Venture Global for twenty years starting in 2030. This agreement brings Venture Global’s long-term contracted portfolio to over 46 MTPA. “Venture Global is thrilled to announce our first long-term supply deal in Korea through a new partnership with Hanwha Aerospace which marks another important step in expanding reliable, long-term LNG supply to our partners in Asia,” said Mike Sabel, CEO of Venture Global. “We are proud to support growing global energy needs with low-cost, secure American LNG while strengthening the strategic energy partnership between the United States and South Korea to support long-term industrial and economic growth.” About Venture Global Ventu
Hydnum Steel Secures 500 MW of Electrical Power, a Key Step Forward in the Construction of Its Clean Steel Plant in Spain27.2.2026 00:00:00 CET | Press release
The company will produce flat steel, a product for which the EU has an annual deficit of almost 11 million tons Hydnum Steel has taken a decisive step towards constructing Spain’s first clean steel plant after being granted access to the electricity grid at the Brazatortas node in the province of Ciudad Real. The company has been granted an electricity capacity of 500 MW, as published in the Official State Gazette, which should be enough to guarantee supply to its electric arc furnace. This concession marks a significant milestone for a pioneering project in the Iberian Peninsula. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260225309290/en/ Image recreating the steel plant that Hydnum Steel will build in Puertollano, Spain Hydnum Steel is consolidating its position as a reliable supplier of clean European steel. The fully digitally integrated plant will produce hot-rolled steel coils efficiently and sustainably, with bene
1089 Inc. Partners with Price Forbes and Oka-Lloyd's Syndicate 1922 to Launch Market-Defining First: Carbon Asset Insurance Framework for Transportation and Energy Sectors26.2.2026 23:01:00 CET | Press release
New program introduces dedicated insurance safeguards and immutable transfer infrastructure to advance fiscal maturation of global carbon markets, enabling scaled participation across world's highest-emitting sectors, Transportation and Energy. 1089 Inc., in collaboration with Price Forbes and Oka, The Carbon Insurance Company, announce launch of an insured carbon asset designed to bring institutional safeguards, disciplined financial architecture, and verifiable data integrity to carbon markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226012782/en/ 1089 Inc. is Advancing Carbon™, focused on evolving global carbon markets and decarbonizing the highest-emitting sectors on the planet: Transportation and Energy. The framework provides defined risk coverage for 1089’s CX89 Advanced Fuels Carbon Assets, underwritten by Lloyd’s Syndicate 1922 and placed with the support of Price Forbes and Oka. The program introduces ins
Sun Nuclear QADS 2026 Event Combines Clinical Insight and New Innovations for Advancing Radiation Therapy QA26.2.2026 23:00:00 CET | Press release
15th QA & Dosimetry Symposium convenes medical physics and radiation therapy community in RomeTwo days of sessions span diverse topics from 24 clinical practitioners and thought leadersEvent introduces new Daily QA™ 4 Pro device and features expansion of AI-enabled solutions Sun Nuclear, a Mirion Medical company, today opened the QA & Dosimetry Symposium (QADS), taking place over the next two days in Rome, Italy. The 15th installment brings together more than 230 clinical physicists and radiation medicine professionals from nearly 40 countries. Participants from diverse clinical environments will earn continuing education credits while sharing practical insights, emerging approaches, and real-world experiences shaping the future of quality and patient safety in cancer care. Building on its legacy as a peer-driven forum with practical applications, QADS 2026 features sessions delivered by 24 speakers spanning: Future Directions in Machine and Patient QA and In-vivo Dosimetry Stereotacti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
